Security key
766559702
RIGEL PHARMACEUTICALS INC - Common Stock, par value $0.001 per share (RIGL)
CUSIP: 766559702
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 10,378,502
- Total 13F value
- $85,309,593
- Share change
- +10,358,897
- Put/Call ratio
- 114%
- SEC-reported price per share
- $8.22
- Number of holders
- 80
- Value change
- +$85,148,446
- Number of buys
- 77
- Shares outstanding
- 18,681,564
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
80
Top holders
10
RIGL full security history
Ownership snapshot
Full 13F holder table
RIGEL PHARMACEUTICALS INC SEC filings
RIGEL PHARMACEUTICALS INC company facts
Broader feeds
Ownership snapshot
Top reported holders of RIGL - RIGEL PHARMACEUTICALS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F
Highest disclosed value: $22,732,800
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC has the largest disclosed position value at $22.73M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 5
ARMISTICE CAPITAL, LLC
$22.73M
BlackRock Finance, Inc.
$21.9M
MORGAN STANLEY
$21.37M
VANGUARD GROUP INC
$13.86M
Soleus Capital Management, L.P.
$13.68M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
class O/S missing
|
$22,732,800
15,360,000 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$21,902,137
14,798,741 shares
|
— | 31 Mar 2024 |
| MORGAN STANLEY |
13F
Company
|
—
class O/S missing
|
$21,372,471
14,440,858 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$13,863,787
9,367,424 shares
|
— | 31 Mar 2024 |
| Soleus Capital Management, L.P. |
13F
Company
|
—
class O/S missing
|
$13,678,139
9,241,986 shares
|
— | 31 Mar 2024 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
—
class O/S missing
|
$8,086,000
5,465,183 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
80
Shares
10,378,502
Rows available
80
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
0
Q2 2024 holders
80
Holder diff
80
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|